Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs Fox Corp Class A (FOXA) Price & Performance

Biogen IncTrade
Fox Corp Class ATrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Fox Corp Class A — how do they compare? Biogen Inc trades at $204 (market cap $30.13B), while Fox Corp Class A trades at $61.87 (market cap $24.58B). The key difference: Biogen Inc is the larger of the two by market cap, and Fox Corp Class A pays a 0.93% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

BIIBFOXA
Market Cap
$30.13B$24.58B
Sector
HealthMedia
52-Week High
$216.63$76.11
52-Week Low
$128.93$48.79
Enterprise Value
$37.20B$27.94B
Dividend Yield
0.93%

Returns comparison

Trailing returns across standard periods

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About Fox Corp Class A

Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.

Read more on FOXA